The revisions make it clear that the federal Drug-Free Workplace Act — passed in 1988 — remains in place, and that federal employees “are required to refrain” from the use of either cannabis or other federally controlled substances “whether on or off duty.” Employees who do not do so will face disciplinary action.
“Suspicionless marijuana testing never has been an evidence-based policy. Rather, these discriminatory practices are a holdover from the zeitgeist of the 1980s ‘war on drugs.’
In light of the first year of legalization, NORML Canada has monitored the Canadian cannabis landscape closely, to determine the next steps for crafting achievable and functional reform of cannabis regulations.
On Wednesday, September 25th, 2019, NORML testified at the DC Council Committee on Labor and Workforce Development in support of B23-0309, which seeks to expand workplace protections for medical cannabis patients in the District of Columbia.
Illinois has an estimated 770,000 marijuana related criminal records which are now eligible for clemency by Governor Pritzker.
The Act states, “A public employer may not refuse to hire, terminate from employment, penalize, fail to promote, or otherwise take adverse employment action against an individual based upon the individual’s status as a qualifying patient.”
Members of NAACP Denver and Minorities for Medical Marijuana join forces to address the lack of diversity and need for social equity within the marijuana industry.
City lawmakers have successfully passed a pair of municipal bills limiting situations where those seeking employment or on probation may be drug tested for past cannabis exposure.